enterobacter 中文意思是什麼
enterobacter
解釋
腸桿菌屬-
Study on drug resistance and molecular epidemiology of enterobacter cloacae infection after liver transplantation
肝移植術后陰溝腸桿菌感染耐藥性及分子流行病學研究 -
Antimicrobial resistance of enterobacter cloacae : a study from shandong provincial nosocomial infection surveillance system
山東省醫院感染監控網陰溝腸桿菌耐藥性分析 -
In vitro studies have demonstrated florfenicol activity against enterobacter cloacae, escherichia coli, klebsiella pneumoniae, salmonella typhi, and shigella dysenteriae
試驗表明，氟苯尼考還能夠抑制陰溝腸桿菌、大腸埃希菌、克雷白氏肺炎菌、傷寒沙門氏菌和志賀氏痢疾桿菌。 -
The results showed that the f fragment, 728bp in length, could be a new gene with a little homology to the genes coding for polyketide synthetase or fatty - acid synthetase and the b fragment, about 4kb in length, is inferred to have repeat sequences around tn5 insertion site, in which there is homology to the wa 314 right arm of the high - pathogeniciry island of yersinia enterocolitica. to reveal any pathogenicity of enterobacter cloacae b8 and its mutated strains b8b and b8f to animals, the experiment with mice was carried out
結果顯示， f片段長度為728bp ，與現有生物數據庫的blast比較分析，發現該序列僅有局部短於1oobp的區域與polyketide合成酶基因或與脂肪酸合成酶基因有低的同源性，推測為一新基因； b片段長約4kb ，序列拼接結果推測靠近tn5插入位點部位有重復序列，對b片段tn5遠端的部分序列進行blast比較，發現它與小腸結腸炎耶爾森氏菌的強毒力島有一定的同源性。 -
Using enterobacter cloacae b8, the mutated strains b8b and b8f, and the recombinant clones pb and pf, we try to sequence the antagonistic - related genes of enterobacter cloacae b8 by subcloning and genome primering system. the acquired sequences were analyzed with blast program to find any homology to sequences deposited in genebank
以廣譜拮抗菌陰溝腸桿菌b8菌株和拮抗活性缺失菌株b8b 、 b8f及從b8b和b8f二菌株克隆獲得的重組質粒pb 、 pf為基礎，對陰溝腸桿菌b8菌株拮抗相關的b和f基因片段進行序列分析。 -
Panipenem and imipenem exhibited comparable in vitro antimicrobial activity, and their activity against gram - negative bacteria such as k. pneumoniae and enterobacter spp was slightly inferior to meropenem, superior to that of ceftazidime, fluroquinolones and - lactam and - lactamase inhibitor combinations
三種碳青黴烯類抗生素體外抗菌作用優于頭孢他啶、 -內酰胺類抗生素與-內酰胺酶抑制劑合劑、氟喹諾酮類等其它受試藥物。 -
Cefepime is indicated for the treatment of infections caused by susceptible gram - positive and gram - negative microorganisms, including enterobacter, escherichia coli, klebsiella pneumoniae, proteus mirabilis, pseudomonas aeruginosa, methicillin - susceptible staphylococcus aureus, streptococcus pneumoniae, streptococcus pyogenes, and viridans group streptococci
頭孢吡肟用於治療敏感革蘭氏陽性菌和革蘭氏陰性菌導致的感染，包括腸道細菌、大腸桿菌、肺炎桿菌、奇異變形桿菌、綠膿假單胞菌、對甲氧西林敏感的金黃色釀膿葡萄球菌、肺炎鏈球菌、化膿性鏈球菌以及草綠色鏈球菌。 -
Antibiotic susceptibility of enterobacter sakazakii isolated from powdered formula for infant and young children
嬰幼兒配方粉中阪崎腸桿菌分離株的藥敏分析 -
In 2005, the number of isolates of enterobacter spp. tested was 1
二零零五年，腸桿菌的測試樣本數目有1個。 -
Of the isolates tested, the percentage of strains resistant to amoxicillin - clavulanic acid was not applicable according to the national committee for clinical laboratory standards or not performed. in 2006, the number of isolates of enterobacter spp. tested was 3
沒有對阿莫西林及克拉維酸的抗藥性進行測試或根據美國national committee for clinical laboratory ，對阿莫西林及克拉維酸的抗藥性測試是不適用的。
分享友人